Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections

PHASE3CompletedINTERVENTIONAL
Enrollment

1,205

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Complicated Urinary Tract Infections
Interventions
DRUG

Eravacycline

DRUG

Ertapenem

DRUG

Placebo

DRUG

Levofloxacin

Trial Locations (69)

31820

Columbus

Unknown

Fullerton

Los Angeles

Torrance

Coral Gables

Doral

Miami

St Louis

Las Vegas

Baytown

Graz

Linz

Salzburg

Pleven

Plovdiv

Razgrad

Rousse

Smyadovo

Sofia

Varna

Veliko Tarnovo

Tallinn

Tartu

Võru

K'ut'aisi

T'bilisi

Baja

Budapest

Miskolc

Nagykanizsa

Nyíregyháza

Sopron

Szentes

Tatabánya

Jelgava

Riga

Valmiera

Chisinau

Brasov

Bucharest

Craiova

Oradea

Arkhangelsk

Moscow

Pyatigorsk

Rostov-on-the-Don

Saint Petersburg

Smolensk

Vsevolozhsk

Yaroslavl

Nitra

Poprad

Prešov

Svidník

Žilina

Chernihiv

Chernivtsi

Dnipro

Ivano-Frankivsk

Kharkiv

Kyiv

Lviv

Mykolaiv

Odesa

Poltava

Uzhhorod

Vinnytsia

Zaporizhia

Zhytomyr

All Listed Sponsors
lead

Tetraphase Pharmaceuticals, Inc

INDUSTRY

NCT03032510 - Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections | Biotech Hunter | Biotech Hunter